Cargando…
JAG1 enhances angiogenesis in triple-negative breast cancer through promoting the secretion of exosomal lncRNA MALAT1
Despite significant improvements in five-year survival rates due to early diagnosis and combination therapy, triple-negative breast cancer (TNBC) treatment remains a major challenge. Finding new and effective targets for diagnosis and drug therapy is urgent for TNBC patients. Jagged-1 (JAG1), one of...
Autores principales: | Liu, Junping, Shi, Yutong, Wu, Minmin, Zhang, Fengmei, Xu, Mengqi, He, Zhiqiang, Tang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363582/ https://www.ncbi.nlm.nih.gov/pubmed/37492742 http://dx.doi.org/10.1016/j.gendis.2022.07.006 |
Ejemplares similares
-
EPC‐derived exosomes promote osteoclastogenesis through LncRNA‐MALAT1
por: Cui, Yigong, et al.
Publicado: (2019) -
Regulatory Networks of LncRNA MALAT-1 in Cancer
por: Fu, Shijian, et al.
Publicado: (2020) -
Finely tuned conformational dynamics regulate the protective function of the lncRNA MALAT1 triple helix
por: Ageeli, Abeer A, et al.
Publicado: (2019) -
Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020) -
MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer
por: Mekky, Radwa Y., et al.
Publicado: (2023)